From July 3 through July 10, 2014, the National IHR Focal Point for Saudi Arabia reported an additional seven laboratory-confirmed cases of infection with Middle East respiratory syndrome coronavirus (MERS-CoV), and the death of a previously reported case.
Details of the case reported on July 3 are as follows:
A 55-year-old woman from Addawaser City, Riyadh Region who became ill on June 25 was admitted to a hospital on July 2 and is currently in a stable condition. She was laboratory-confirmed with MERS-CoV infection on July 3. She is reported to have an underlying medical condition. The patient’s husband owns a camel farm which she visits frequently. She is reported not to have consumed raw camel products in the 14 days prior to becoming ill. She is reported not to have contact with a previously laboratory-confirmed case with MERS-CoV infection. On June 15, she traveled to Riyadh City where she stayed for a day. Investigations into the contacts of the patient are ongoing.
Details of the two cases reported July 5-6 are as follows:
A 52-year-old man residing in Jeddah City, Makkah Region became ill on June 24 and visited a private clinic but his condition did not improve. He was admitted to a hospital on July 2 with respiratory problems and renal failure and is currently in a critical condition. The patient was laboratory-confirmed with MERS-CoV infection on July 4. He does not have a history of travel.
A 72-year-old man from Arar City, Northern Bordes Province became ill and was admitted to a hospital on July 3. He was laboratory-confirmed with MERS-CoV infection on July 5. The patient died on 6 July. He had multiple underlying medical conditions. He had no history of recent travel and did not have contact with a previously laboratory-confirmed case with MERS-CoV infection. The patient has no history of consumption of raw camel products.
Details of the three cases reported on July8 are as follow:
A 70-year-old man from Taif City, Mecca Region who became ill on June 28 was admitted to a hospital on July 4 and is currently in intensive care. The patient was laboratory-confirmed with MERS-CoV infection on July 6. He is reported to have underlying medical conditions. The patient is reported to have no history of travel and no contact with a previously laboratory-confirmed case with MERS-CoV infection. The patient is reported to have consumed raw camel milk a week prior to his illness and has had close contact with goats he raises.
A 74-year-old man from Riyadh city, Riyadh Region who became ill on July 4, was admitted to a hospital on July 5 and is currently in a stable condition. He was laboratory-confirmed with MERS-CoV infection on July 6. The patient is reported not to have any underlying medical condition. He did not have a history of travel 14 days prior to becoming ill and has no known contact with a previously laboratory-confirmed case with MERS-CoV infection. He has no history of contact with animals or consumption of raw camel products.
A 70-year-old man from Riyadh City, Riyadh Region who became ill on July 1 was admitted to a hospital on July 5 and is currently in a stable condition. He was laboratory-confirmed with MERS-CoV on Jul 6. The patient is reported to have an underlying medical condition. He has no history of travel 14 days prior to becoming ill and is not known to have contact with a previously laboratory-confirmed case of infection with MERS-CoV. He has no history of consumption of raw camel products within the 14 days prior to becoming ill and did not have contact with animals.
Details of the three cases reported on July 19 are as follow:
A 49-year-old man from Hassa City, Eastern Region who became ill on June 28 was admitted to a hospital on July 8 and is currently in a stable condition. He was laboratory-confirmed with MERS-CoV infection on July 9. The patient is reported to have underlying medical conditions. He has no history of travel and did not have contact with a previously laboratory-confirmed case with MERS-CoV infection. The patient has a farm and had direct contact with birds, goats and camels. Samples have been taken from 15 contacts of the patient, the farm workers and camels for laboratory testing. Investigations into the contacts of the patients are ongoing.
Globally, 834 laboratory-confirmed cases of infection with MERS-CoV including at least 288 related deaths have officially been reported to the World Health Organization (WHO).
Infection prevention and control measures are critical to prevent the possible spread of MERS-CoV in healthcare facilities. It is not always possible to identify patients with MERS-CoV early because like other respiratory infections, the early symptoms of MERS-CoV are non-specific. Therefore, healthcare workers should always apply standard precautions consistently with all patients, regardless of their diagnosis. Droplet precautions should be added to the standard precautions when providing care to patients with symptoms of acute respiratory infection; contact precautions and eye protection should be added when caring for probable or confirmed cases of MERS-CoV infection; airborne precautions should be applied when performing aerosol generating procedures.
Until more is understood about MERS-CoV, people with diabetes, renal failure, chronic lung disease, and immunocompromised persons are considered to be at high risk of severe disease from MERSCoV infection. Therefore, these people should avoid close contact with animals, particularly camels, when visiting farms, markets, or barn areas where the virus is known to be potentially circulating. General hygiene measures such as regular hand washing before and after touching animals and avoiding contact with sick animals, should be adhered to.
Food hygiene practices should be observed. People should avoid drinking raw camel milk or camel urine, or eating meat that has not been properly cooked.
WHO does not advise special screening at points of entry with regard to this event nor does it currently recommend the application of any travel or trade restrictions.
Source: WHO
Revolutionizing Hospital Cleanliness: How Color Additives Transform Infection Prevention
December 9th 2024Discover how a groundbreaking color additive for disinfectant wipes improved hospital cleanliness by 69.2%, reduced microbial presence by nearly half, and enhanced cleaning efficiency—all without disrupting workflows.
Splash Pads and Waterborne Disease Outbreaks: A 25-Year Perspective Introduction
December 5th 2024A CDC report reveals 25 years of splash pad-linked waterborne outbreaks, highlighting risks from pathogens like Cryptosporidium. Prevention requires better hygiene, water treatment, and public health strategies.
Piloting Change Management: Tools for Infection Preventionists to Drive Impactful Change
December 5th 2024Infection preventionists play a vital role in health care, leveraging change management techniques to overcome resistance, unite stakeholders, and implement strategies prioritizing patient safety.